Everolimus and Pemetrexed drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Everolimus (everolimus) and Pemetrexed (pemetrexed). Common drug interactions include pulmonary haemorrhage among females and ascites among males.

The phase IV clinical study analyzes what interactions people have when they take Everolimus and Pemetrexed. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Everolimus?

Everolimus has active ingredients of everolimus. eHealthMe is studying from 16,228 Everolimus users. Check the latest studies of Everolimus.

What is Pemetrexed?

Pemetrexed has active ingredients of pemetrexed. eHealthMe is studying from 17,491 Pemetrexed users. Check the latest studies of Pemetrexed.

On Jul, 12, 2026

19 people who take Everolimus and Pemetrexed together, and have interactions are studied.

Everolimus and Pemetrexed drug interactions.

What are the common drug interactions of Everolimus and Pemetrexed, by gender? *:

female:

Pulmonary haemorrhage (acute bleeding from the lung)
Pulmonary embolism (blockage of the main artery of the lung)
Disease progression
Pulmonary mass
Malignant neoplasm progression (cancer tumour came back)
Metastases to lung (cancer spreads to lung)
Pleurisy (inflammation of the pleurae, which causes pain when breathing)

male:

Ascites (accumulation of fluid in the abdominal cavity)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Hepatotoxicity (chemical-driven liver damage)
Erysipelas (bacterial skin infection)
Lymphoedema (localized fluid retention and tissue swelling)
Malignant neoplasm progression (cancer tumour came back)
Oedema peripheral (superficial swelling)
Pleural effusion (water on the lungs)
Pneumonia
Renal failure (kidney dysfunction)

What are the common drug interactions of Everolimus and Pemetrexed, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pulmonary haemorrhage (acute bleeding from the lung)
Pulmonary embolism (blockage of the main artery of the lung)
Pulmonary mass

40-49:

Pleurisy (inflammation of the pleurae, which causes pain when breathing)

50-59:

n/a

60+:

Malignant neoplasm progression (cancer tumour came back)
Ascites (accumulation of fluid in the abdominal cavity)
Disease progression
Metastases to lung (cancer spreads to lung)
Pulmonary embolism (blockage of the main artery of the lung)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Erysipelas (bacterial skin infection)
Lymphoedema (localized fluid retention and tissue swelling)
Oedema peripheral (superficial swelling)
Pleural effusion (water on the lungs)

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 4 people, 21.05%
Metastatic Bronchial Carcinoma (spread of cancer to bronchi tumour): 4 people, 21.05%
Thymoma (a tumour originating from the epithelial cells of the thymus): 3 people, 15.79%
Breast Cancer: 2 people, 10.53%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 5.26%
Metastatic Neoplasm (spreadable cancer tumour): 1 person, 5.26%
Lung Adenocarcinoma Stage Iii (the cancer has spread to nearby tissue or too far away lymph nodes): 1 person, 5.26%
Bronchial Carcinoma (lung cancer): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Everolimus and Pemetrexed?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously